Skip to main content

Table 3 HrHPV prevalence and compliance with follow-up in self-samplers, stratified by age groups

From: Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial

 

HrHPV prevalence

Compliance with follow-up within (days)

Total

  

≤ 30

31–60

61–90

 
 

N

na (%)

nb(%)

nb(%)

nb(%)

nb(%)

Age (years)

 30–39

312

49 (15.7)

40 (81.6)

2 (4.1)

2 (4.1)

44 (89.8)

 40–49

397

48 (12.1)

31 (64.6)

9 (18.8)

4 (8.3)

44 (91.7)

 50–64

196

21 (10.7)

11 (52.4)

7 (33.3)

1 (4.8)

19 (90.5)

 Total

905

118 (13.0)

82 (69.5)

18 (15.3)

7 (5.9)

107 (90.7)

  1. N: Number of received self-samples. na: Number of women with a hrHPV-positive self-sample. nb: Number of women with a cervical cytology triage sample
  2. %: Row percentages